Suppr超能文献

解脲脲原体在早产(<34周)新生儿气道定植的临床意义。

Clinical significance of airways colonization with Ureaplasma urealyticum in premature (<34 wk) neonates.

作者信息

Pandey Anubhav, Dhawan Benu, Gupta Vikas, Chaudhry Rama, Deorari A K

机构信息

Department of Microbiology , All India Institute of Medical Sciences New Delhi, India.

出版信息

Indian J Med Res. 2007 May;125(5):679-84.

Abstract

BACKGROUND & OBJECTIVE: Ureaplasma urealyticum has been implicated in various neonatal morbidities in preterm infants. Its association with chronic lung disease (CLD) remains controversial. The aim of this prospective study was to investigate colonization of U. urealyticum in preterm infants (with gestational age <34 wk) and to evaluate the relationship between U. urealyticum colonization and neonatal morbidity including CLD.

METHODS

U. urealyticum was cultured from nasopharyngeal or endotracheal aspirates collected within 24 h of birth from infant <or=34 wk gestation weighing <1800 g admitted to a Neonatal Intensive Care Unit of a tertiary care hospital in north India, and PCR was performed on the DNA extracted from these samples.

RESULTS

Twenty per cent of the study infants were colonized with U. urealyticum. The mean gestational age of the infants in the colonized group was less than that of non colonized infants (P<0.05). The peripheral total leukocyte counts and mortality rate were higher in infants with U. urealyticum colonization than in non-colonized infants (P<0.05). There was no significant difference between the colonized and non colonized groups with regard to the antenatal use of steroids, sex, cause of respiratory distress, use of surfactant, duration of ventilation.

INTERPRETATION & CONCLUSION: None of the 20 babies colonized with U. urealyticum developed CLD as compared with two (2.5%) of the non colonized group. Colonization of the airways with U. urealyticum had no significant role in development of CLD in Indian preterm infants.

摘要

背景与目的

解脲脲原体与早产儿的多种新生儿疾病有关。其与慢性肺病(CLD)的关联仍存在争议。这项前瞻性研究的目的是调查解脲脲原体在早产儿(胎龄<34周)中的定植情况,并评估解脲脲原体定植与包括CLD在内的新生儿疾病之间的关系。

方法

从印度北部一家三级护理医院新生儿重症监护病房收治的胎龄≤34周、体重<1800 g的婴儿出生后24小时内采集的鼻咽或气管内吸出物中培养解脲脲原体,并对从这些样本中提取的DNA进行聚合酶链反应(PCR)。

结果

20%的研究婴儿定植了解脲脲原体。定植组婴儿的平均胎龄低于未定植婴儿(P<0.05)。解脲脲原体定植婴儿的外周血白细胞总数和死亡率高于未定植婴儿(P<0.05)。在产前使用类固醇、性别、呼吸窘迫原因、表面活性剂使用、通气时间方面,定植组和未定植组之间没有显著差异。

解读与结论

与未定植组的2例(2.5%)相比,20例定植了解脲脲原体的婴儿均未发生CLD。在印度早产儿中,气道定植解脲脲原体在CLD的发生中没有显著作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验